Brief: Expres2ion Evaluates Strategic Options For Its Breast Cancer Vaccine Candidate

ExpreS2ion Biotech Holding AB

17/08/2023 08:46

Aug 17 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION EVALUATES STRATEGIC OPTIONS FOR ITS BREAST
CANCER
VACCINE CANDIDATE
    * INITIATES A COST REDUCTION PROGRAM
    * OUR NEAR-TERM CASH POSITION ENABLES US TO MAINTAIN CURRENT
ACTIVITY LEVEL INTO 2024
    * CURRENT FINANCIAL OUTLOOK MAKES IT UNLIKELY TO RAISE CASH
REQUIRED TO COMMIT TO COSTS ASSOCIATED WITH A PHASE I CLINICAL
STUDY
    * DECISION HAS BEEN MADE TO PAUSE PROGRAM AND FOCUS ON
IDENTIFYING
NEW WAYS TO BRING ASSET FORWARD
    * WILL INITIATE A REVIEW OF EXPRES(2)ION'S STRATEGY,
PIPELINE AND
ORGANIZATION

Source text for Eikon:  ID:nWkr3NLxLG 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))